There is a statistical difference in blood glucose on admission between survivors and non-survivors in the whole cohort study with TTP patients (P = 0.000) and in the cohort between 2013 and 2021 with available ADAMTS13 data cases (P = 0.027). The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.